BioCare, a specialty pharmaceutical distributor comprised of BioCareSD and LogiCare3PL, announced on Wednesday that Inc. Magazine has named the company in the 2026 Inc. 5000, its annual list recognising the fastest-growing private companies in America.
BioCare says that it delivers life-saving and life-changing therapies through high-touch service and a differentiated distribution model.
The company ranked No. 2520 on the 2026 list, climbing 1,145 spots from its 2025 ranking of No. 3665. This marks the fourth consecutive year BioCare has earned a place on the Inc. 5000. Based on revenue growth from 2023 to 2025, this year's ranking reflects the company's 129% growth over the three-year period.
MaaT Pharma to seek review after CHMP negative opinion on MaaT013 application
Sensei Biotherapeutics changes name to Faeth Therapeutics
Datavault AI and Wellgistics Health plan DelivMeds AI healthcare venture
Intensity Therapeutics receives Cancer Treatment Technology Innovator of the Year award
Solvonis Therapeutics appoints Water Tower Research to strengthen US market positioning
Atrium Therapeutics announces inducement grants to seven new employees
GXO appointed to manage NHS England bowel cancer home testing kits